167 related articles for article (PubMed ID: 26137891)
1. Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-α treatment.
Borekci S; Atahan E; Demir Yilmaz D; Mazıcan N; Duman B; Ozguler Y; Musellim B; Hamuryudan V; Ongen G
Respiration; 2015; 90(3):191-8. PubMed ID: 26137891
[TBL] [Abstract][Full Text] [Related]
2. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
Jo KW; Hong Y; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2013 Nov; 107(11):1797-802. PubMed ID: 24029000
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
Sichletidis L; Settas L; Spyratos D; Chloros D; Patakas D
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1127-32. PubMed ID: 17044206
[TBL] [Abstract][Full Text] [Related]
4. Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy.
Ozguler Y; Hatemi G; Ugurlu S; Seyahi E; Melikoglu M; Borekci S; Atahan E; Ongen G; Hamuryudan V
Rheumatol Int; 2016 Dec; 36(12):1719-1725. PubMed ID: 27699578
[TBL] [Abstract][Full Text] [Related]
5. Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence.
Kisacik B; Pamuk ON; Onat AM; Erer SB; Hatemi G; Ozguler Y; Pehlivan Y; Kilic L; Ertenli I; Can M; Direskeneli H; Keser G; Oksel F; Dalkilic E; Yilmaz S; Pay S; Balkarli A; Cobankara V; Cetin GY; Sayarlioglu M; Cefle A; Yazici A; Avci AB; Terzioglu E; Ozbek S; Akar S; Gul A
J Rheumatol; 2016 Mar; 43(3):524-9. PubMed ID: 26773107
[TBL] [Abstract][Full Text] [Related]
6. The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies.
Ai JW; Zhang S; Ruan QL; Yu YQ; Zhang BY; Liu QH; Zhang WH
J Rheumatol; 2015 Dec; 42(12):2229-37. PubMed ID: 26472414
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area.
Kim HW; Park JK; Yang JA; Yoon YI; Lee EY; Song YW; Kim HR; Lee EB
Clin Rheumatol; 2014 Sep; 33(9):1307-12. PubMed ID: 24057090
[TBL] [Abstract][Full Text] [Related]
8. Risk of tuberculosis in rheumatoid arthritis patients on tumour necrosis factor-alpha inhibitor treatment in Taiwan.
Ke WM; Chen LS; Parng IM; Chen WW; On AW
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1590-5. PubMed ID: 24200274
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for tuberculosis in patients receiving tumour necrosis factor-α blockers: what do we really know?
Botha PR; Koegelenberg CF
Respiration; 2015; 90(3):185-6. PubMed ID: 26278409
[No Abstract] [Full Text] [Related]
10. Risk of tuberculosis, serious infection and lymphoma with disease-modifying biologic drugs in rheumatoid arthritis patients in Taiwan.
Chiu YM; Lang HC; Lin HY; Yang MT; Fang CH; Yang YW; Schabert VF; Tang B
Int J Rheum Dis; 2014 Dec; 17 Suppl 3():9-19. PubMed ID: 25496045
[TBL] [Abstract][Full Text] [Related]
11. The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents.
Ergun T; Seckin D; Baskan Bulbul E; Onsun N; Ozgen Z; Unalan P; Alpsoy E; Karakurt S
Int J Dermatol; 2015; 54(5):594-9. PubMed ID: 25753908
[TBL] [Abstract][Full Text] [Related]
12. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
Pamuk ÖN; Kalyoncu U; Aksu K; Omma A; Pehlivan Y; Çağatay Y; Küçükşahin O; Dönmez S; Çetin GY; Mercan R; Bayındır Ö; Çefle A; Yıldız F; Balkarlı A; Kılıç L; Çakır N; Kısacık B; Öksüz MF; Çobankara V; Onat AM; Sayarlıoğlu M; Öztürk MA; Pamuk GE; Akkoç N
Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456
[TBL] [Abstract][Full Text] [Related]
13. Risk of tuberculosis is increased in Behçet’s disease compared to other rheumatological disorders after anti-TNFα treatments: a case series and review of the literature.
Gazel Ü; Kocakaya D; Hicret Topçu İ; Ömer Karataş H; Karabacak M; Atagündüz MP; İnanç GN; Alibaz Öner F; Direskeneli RH
Turk J Med Sci; 2021 Aug; 51(4):1689-1694. PubMed ID: 33535732
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of 1887 patients receiving tumor necrosis-alpha antagonists: Tuberculin skin test conversion and tuberculosis risk.
Cagatay T; Bingol Z; Kıyan E; Yegin Z; Okumus G; Arseven O; Erkan F; Gulbaran Z; Erelel M; Ece T; Cagatay P; Kılıçaslan Z
Clin Respir J; 2018 Apr; 12(4):1668-1675. PubMed ID: 29028148
[TBL] [Abstract][Full Text] [Related]
15. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
16. Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong--the role of TNF blockers in an area of high tuberculosis burden.
Tam LS; Leung CC; Ying SK; Lee GK; Yim CW; Leung YY; Kun EW; Wong KK; Li EK
Clin Exp Rheumatol; 2010; 28(5):679-85. PubMed ID: 20822708
[TBL] [Abstract][Full Text] [Related]
17. Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors.
Kim YJ; Kim YG; Shim TS; Koo BS; Hong S; Lee CK; Yoo B
Rheumatology (Oxford); 2014 Aug; 53(8):1477-81. PubMed ID: 24681840
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of anti-tumor necrosis factor therapy in South African rheumatoid arthritis patients.
Pettipher C; Rudolph R; Musenge E; Tikly M
Int J Rheum Dis; 2016 Jun; 19(6):594-9. PubMed ID: 24517208
[TBL] [Abstract][Full Text] [Related]
19. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases.
Hatzara C; Hadziyannis E; Kandili A; Koutsianas C; Makris A; Georgiopoulos G; Vassilopoulos D
Ann Rheum Dis; 2015 Oct; 74(10):1848-53. PubMed ID: 24854354
[TBL] [Abstract][Full Text] [Related]
20. Incidences of serious infections and tuberculosis among patients receiving anti-tumor necrosis factor-α therapy.
Yoo IK; Choung RS; Hyun JJ; Kim SY; Jung SW; Koo JS; Lee SW; Choi JH; Kim H; Lee HS; Keum B; Kim ES; Jeen YT
Yonsei Med J; 2014 Mar; 55(2):442-8. PubMed ID: 24532516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
